SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?


To: aknahow who wrote (10255)5/28/1999 6:16:00 PM
From: Bluegreen  Read Replies (1) | Respond to of 17367
 
Nope, it isn't me. If I want to joke around with you or anyone else I do it on this board as many can attest to how testy I can be.



To: aknahow who wrote (10255)5/28/1999 6:56:00 PM
From: Pseudo Biologist  Read Replies (1) | Respond to of 17367
 
OT - surely you jest:

from m-w.com

Main Entry: 2polyglot
Function: adjective
Etymology: Greek polyglOttos, from poly- + glOtta language -- more at GLOSS
Date: 1656
1 a : speaking or writing several languages : MULTILINGUAL b : composed of numerous linguistic groups <a polyglot population>
2 : containing matter in several languages <a polyglot sign>
3 : composed of elements from different languages
4 : being widely diverse (as in ethnic or cultural origins) <polyglot cuisine>

... back to the cave now




To: aknahow who wrote (10255)5/28/1999 7:29:00 PM
From: Tharos  Respond to of 17367
 
George,
Nice action on a moderate volume day. These are the kind of days we want, shows an implied strength in the stock.

Might find this useful: reesegroup.com

Disclaimer

Xoma is a biotech company, which, in my opinion, may have investment potential. However, investments in these companies should be considered very high risk investments and only sophisticated investors with very high risk tolerances should consider investing in these companies. My opinion, the information and the projections contained in this commentary are based on factual information, assumptions, hypotheses, projections and theories which I consider reliable. Factual information is provided as of a specified date and may have changed from that date to the present. Projected results may vary widely and I give no warranty or assurances as to the performance of this security or its marketability or liquidity. I may but am under no obligation to provide limited follow-up information concerning this company and may discontinue providing further information without notice. I disclaim responsibility for any false, misleading or deceptive information contained in this report or in any follow-up reports unless I had prior knowledge they were false, misleading or deceptive. I am not a registered adviser or registered dealer of securities and am not authorized to sell or solicit offers to purchase or trade in securities in any jurisdiction where the securities of the this company is permitted to trade. This is not intended to be a solicitation for the sale of securities, nor is it intended as a recommendation to buy, sell or hold securities. All trading in the securities of this company should be transacted through qualified dealers only with appropriate accompanying disclosures after consultation with professional qualified advisors.